Sanofi gets extension on Eu3.7bn facility
Sanofi-Aventis, the French pharmaceutical company, closed the books on an extension to a Eu3.7bn facility on Thursday. The deal was coordinated by the borrower and BNP Paribas.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
